Financial Information Archive until March 2025

​​​​​​The bond issued by DNA Plc, which was listed on the Nasdaq Helsinki stock exchange, matured on Thursday, March 27, 2025. At the same time, DNA's disclosure obligation ended.

DNA will continue to provide information on major events through press releases even after the end of the disclosure obligation. This information also includes the company's key performance and sustainability information.

However, DNA will no longer publish stock exchange releases, information about general meetings or official financial reports, such as consolidated financial statements. Old publications have been archived in to a public archive. All official DNA figures are reported as part of the stock exchange reporting of our parent company, Telenor ASA, which is listed on the Oslo Stock Exchange.

DNA’s Initial Public Offering was arranged on 15–24 November 2016

DNA Plc listed its shares on the official list of Nasdaq Helsinki Ltd (“Helsinki Stock Exchange”).

The listing of the company's shares on the Nasdaq Helsinki stock exchange ended on February 3, 2020.

In the IPO, shares are offered to private individuals and entities in Finland, permanent or fixed-term employees of DNA or its subsidiaries in Finland and all agency employees who work at DNA during the subscription period, the members of the Board of Directors and the CEO of DNA, and institutional investors both in Finland and internationally. 

Important dates

  • 15 November 2016 The subscription period of the IPO begins
  • 24 November 2016 The subscription period of the Public and Personnel Offering ends 
  • 29 November 2016 Press release on the final result of the IPO
  • 30 November 2016 Trading with the shares begins on the prelist of the Helsinki Stock Exchange, excluding the personnel shares
  • 2 December 2016 Trading with the shares begins on the official list of the Helsinki Stock Exchange

Materials